Catalyst Wire Dossier Catalyst Wire Dossier

Zanubrutinib-rituximab (ZR)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zanubrutinib-rituximab (ZR), covering 2022-08-17 to 2022-08-17. Get the full timeline:

Most recent: Clinical Trial Update: Zanubrutinib-rituximab(ZR) in Patients With Newly Diagnosed Untreated Mantle Cell Lymphoma [Phase 2]

See pricing